Smoking history and adherence to cancer-related recommendations in a primary care setting

Using EPIC Campaigns to Increase Breast Cancer Screening Completion of Government-Insured and Uninsured Women in a Community Setting

PURPOSE

The aim of this study was to evaluate EPIC Campaigns (Verona, WI) as a quality improvement initiative to reach our community's uninsured and Medicaid-enrolled patients overdue for screening mammography, describing effectiveness in outreach and factors associated with screening mammography completion.

METHODS

In March of 2024, screening completion percentages for the Emplify Health by Gundersen patient population were 63.7% for Medicaid patients and 61% for uninsured patients. Using the tool EPIC Campaigns, uninsured or Medicaid-enrolled women aged 40 to 74 years who were overdue for a screening mammogram were identified. Eligible patients were notified of their overdue status via their preferred contact method (patient portal message, text, or postal service) and provided instruction on how to schedule a screening mammogram. Rate of screening completion within 6 months of contact was the central outcome. Rates were analyzed by patient demographics as well as community residence type and social determinants of health (SDOH) using univariate tests-Pearson χ2 or Fisher exact-and multiple regression modeling.

RESULTS

We contacted 5,336 women who were overdue for breast cancer screening as of March 2024. Of those, 701 (13%) completed screening mammography within 6 months of our initial contact. The screening completion rate was significantly higher for women on Medicaid versus those who were uninsured (15% versus 6.4%, respectively; P < .001). Screening completion rates were significantly different between community residence types (P = .031). Sixty-eight percent of the study population lived in rural underserved, rural, or rural advantaged communities, the screening completion rates of which were 11% versus 15% versus 14%, respectively. SDOH had varying effects on screening completion rates.

CONCLUSION

For practices using the EPIC electronic health record, EPIC Campaigns is an outreach option that can be tailored by various parameters to achieve goals such as increasing breast cancer screening completion. Thirteen percent of Medicaid-enrolled and uninsured women who were overdue for breast cancer screening completed breast cancer screening within 6 months of initial contact, with a higher completion rate in Medicaid-enrolled women. Various SDOH affected screening completion.

Cancer screening prevalence and preference among hospitalized women with and without diabetes mellitus

OBJECTIVE

To determine the prevalence of nonadherence to breast cancer and colorectal cancer screening, associated risk factors, and screening preference among hospitalized women with and without diabetes aged 50-75 years who were cancer-free at baseline.

METHODS

A prospective study compared women with and without diabetes who were cancer-free (except for skin cancer) at baseline and between 50 and 75 years of age, admitted to the general medical service at an academic center were approached for study participation from December 1, 2014, to May 31, 2017. The study evaluated breast and colorectal cancer screening nonadherence prevalence, preference for screening locale, sociodemographic and clinical variables associated with nonadherence using multivariable logistic regression model.

RESULTS

Of 510 women, 39% had a prior diagnosis of diabetes mellitus, and 36% were African American. Women with diabetes were more likely to have obesity, reliance on assistive devices for ambulation, inability to work (have a disability), and a greater average number of comorbidities compared to women without diabetes. Women with or without diabetes were equally nonadherent with BRC (28% vs 36%, p = 0.6) and CRC (25% vs 28%, p = 0.51) screening guidelines. After adjustment for sociodemographic and clinical risk factors, only high risk for CRC (OR = 3.20, 95%CI; 1.03-9.91) was an independent risk factor associated with nonadherence to BRC among hospitalized women with diabetes. Whereas after similar adjustment, age younger than 60 years (OR = 2.91, 95%CI; 1.15-7.35) and current or prior smoking (OR = 2.80, 95%CI; 1.14-6.86) were associated with nonadherence to CRC among women with diabetes. 46% of women with diabetes expressed a preference for in-hospital screening for BRC, while 45% expressed a similar preference for CRC.

CONCLUSION

Hospitalizations may offer additional screening opportunities as almost half of the women with diabetes preferred undergoing breast and colorectal cancer screening during a hospital stay.

Bridging the Gap: Interventions to Increase Cancer Screening Adherence in Individuals with Mental Disorders-A Systematic Review

Patients with mental illnesses adhere to organized cancer screening programs less frequently than the general population. This systematic review aims to examine the literature to identify studies that evaluate interventions designed to increase cancer screening adherence in people with mental disorders. The review protocol was registered (CRD42024510431) and Pubmed and Scopus were searched up to January 2024. Breast, colorectal, or cervical cancer screening were considered. We adhered to the PROSPERO guidelines. Study quality was assessed. Overall, six articles were included: two RCT studies, two before-after studies, and two cohort studies. Four interventions were conducted in the USA, one in Canada, and one in Japan. Two studies evaluated all three cancer screening programs, two studies evaluated breast cancer screenings, and two studies evaluated colorectal cancer screenings. The proposed interventions included patient navigation, case management, and support from staff members along with educational modules, decision counselling sessions, and enhanced primary care. The most consistent improvements in screening adherence were observed in breast and colorectal cancer screenings compared to usual care, particularly through interventions like patient navigation (colorectal cancer: 47.1% vs. 11.8%, p < 0.001) and case management. Further evaluations of interventions and their costs are still needed.

Regional Impact of the COVID-19 Pandemic on Cancer Screening

Cancer screening is the most cost-effective prevention strategy that enables improved cancer morbidity and mortality rates. However, there was a significant decline in cancer screening during the COVID-19 pandemic worldwide. This study aimed to measure regional differences in cancer screening by comparing screening rates before and during COVID-19 and to examine factors explaining the regional difference in cancer screening. All variables including the differences in cancer screening rate before and during the COVID-19 pandemic were collected from 229 administrative subregions in South Korea and joined with each community in ArcGIS environment. Factors explaining regional difference in cancer screening were analyzed through descriptive statistics, correlation analysis, and interactive decision tree modeling. Cancer screening rates decreased in all regions during the COVID-19 pandemic in South Korea. The findings revealed that national health insurance premiums, the number of cancer screening facilities, livelihood benefit recipients, and the population aged 65+ could be classified as variables highly affecting the decrease in cancer screening rate. These findings highlight the efforts to appraise different barriers to cancer screening in each community. In addition, it is important to promote sustainable cancer screening strategies from regional perspectives based on regional vulnerabilities and their complex impact on cancer screening.

Patient Perspectives on a Patient-Facing Tool for Lung Cancer Screening

BACKGROUND

Individuals with high risk for lung cancer may benefit from lung cancer screening, but there are associated risks as well as benefits. Shared decision-making (SDM) tools with personalized information may provide key support for patients. Understanding patient perspectives on educational tools to facilitate SDM for lung cancer screening may support tool development.

AIM

This study aimed to explore patient perspectives related to a SDM tool for lung cancer screening using a qualitative approach.

METHODS

We elicited patient perspectives by showing a provider-facing SDM tool. Focus group interviews that ranged in duration from 1.5 to 2 h were conducted with 23 individuals with high risk for lung cancer. Data were interpreted inductively using thematic analysis to identify patients' thoughts on and desires for a patient-facing SDM tool.

RESULTS

The findings highlight that patients would like to have educational information related to lung cancer screening. We identified several key themes to be considered in the future development of patient-facing tools: barriers to acceptance, preference against screening and seeking empowerment. One further theme illustrated effects of patient-provider relationship as a limitation to meeting lung cancer screening information needs. Participants also noted several suggestions for the design of technology decision aids.

CONCLUSION

These findings suggest that patients desire additional information on lung cancer screening in advance of clinical visits. However, there are several issues that must be considered in the design and development of technology to meet the information needs of patients for lung cancer screening decisions.

PATIENT OR PUBLIC CONTRIBUTION

Patients, service users, caregivers or members of the public were not involved in the study design, conduct, analysis or interpretation of the data. However, clinical experts in health communication provided detailed feedback on the study protocol, including the focus group approach. The study findings contribute to a better understanding of patient expectations for lung cancer screening decisions and may inform future development of tools for SDM.

Understanding mechanisms of racial disparities in breast cancer: an assessment of screening and regular care in the Carolina Breast Cancer Study

PURPOSE

Screening history influences stage at detection, but regular preventive care may also influence breast tumor diagnostic characteristics. Few studies have evaluated healthcare utilization (both screening and primary care) in racially diverse screening-eligible populations.

METHODS

This analysis included 2,058 women age 45-74 (49% Black) from the Carolina Breast Cancer Study, a population-based cohort of women diagnosed with invasive breast cancer between 2008 and 2013. Screening history (threshold 0.5 mammograms per year) and pre-diagnostic healthcare utilization (i.e. regular care, based on responses to "During the past ten years, who did you usually see when you were sick or needed advice about your health?") were assessed as binary exposures. The relationship between healthcare utilization and tumor characteristics were evaluated overall and race-stratified.

RESULTS

Among those lacking screening, Black participants had larger tumors (5 + cm) (frequency 19.6% vs 11.5%, relative frequency difference (RFD) = 8.1%, 95% CI 2.8-13.5), but race differences were attenuated among screening-adherent participants (10.2% vs 7.0%, RFD = 3.2%, 0.2-6.2). Similar trends were observed for tumor stage and mode of detection (mammogram vs lump). Among all participants, those lacking both screening and regular care had larger tumors (21% vs 8%, RR = 2.51, 1.76-3.56) and advanced (3B +) stage (19% vs 6%, RR = 3.15, 2.15-4.63) compared to the referent category (screening-adherent and regular care). Under-use of regular care and screening was more prevalent in socioeconomically disadvantaged areas of North Carolina.

CONCLUSIONS

Access to regular care is an important safeguard for earlier detection. Our data suggest that health equity interventions should prioritize both primary care and screening.

Factors Influencing Willingness to Undergo Lung Cancer Screening in the Future: A Cross-Sectional Study of Japanese University Students

Lung cancer (LC) is currently the leading cause of cancer deaths in Japan. Early detection through lung cancer screening (LCS) is important for reducing mortality. Therefore, exploring the factors affecting willingness to undergo LCS, particularly among young people, is important. This study aimed to elucidate the inclination toward LCS and its determining factors among Japanese university students. This cross-sectional study, involving 10,969 Japanese university students, was conducted in April 2023. A Pearson's chi-square test and a binomial logistic regression analysis were used to analyze factors related to the dependent variable, willingness to undergo LCS in the future. Out of the 6779 participants (61.8%) involved in this study, 6504 (95.9%) provided valid responses, and 4609 (70.9%) expressed a willingness to undergo LCS in the future. Analysis revealed current smoking as a barrier to future willingness to undergo LCS. Other barriers included postponing the age of screening, anxiety about the screening content, and concerns about the possibility of having cancer after screening. Addressing barriers, such as current smoking and anxiety about screening, that prevent young people from undergoing LCS in the future is crucial. Therefore, universities should provide opportunities to educate students about LCS and explore various educational methods.

Cervical cancer screening among English- and Spanish-speaking Hispanic women in an urban safety net health system, 2015-2020

BACKGROUND

The Hispanic population is heterogeneous with differences in health behaviors across subgroups by nativity and preferred language. We evaluated cervical cancer screening adherence among English- and Spanish-speaking Hispanic patients receiving care at a safety net health system.

METHODS

Electronic health records were used to identify 46,094 women aged 30-65. Up to date (UTD) screening was defined based on date of last Pap test, human papillomavirus (HPV) test, or Pap/HPV co-test.

RESULTS

Overall, 81.5% of 31,297 Hispanic women were UTD. English-speaking Hispanic women had a lower prevalence of being UTD when compared to Spanish-speaking Hispanic women (aPR: 0.94, 95% CI: 0.93 - 0.96). Further, those with indigent healthcare plans had a higher prevalence of being UTD when compared to those with private insurance (aPR: 1.10, 95% CI: 1.09 - 1.12), while all other health insurance plans were associated with lower UTD screening when compared to private insurance.

CONCLUSIONS

These findings suggest screening differences within the Hispanic population, highlighting the need for disaggregated research assessing heterogeneity within racial/ethnic groups, specifically among Hispanic populations.

The Global, Regional, and National Burdens of Cervical Cancer Attributable to Smoking From 1990 to 2019: Population-Based Study

BACKGROUND

Cervical cancer is the fourth most common cause of cancer death in women worldwide. Smoking is one of the risk factors for cervical cancer. Understanding the global distribution of the disease burden of cervical cancer attributable to smoking and related changes is of clear significance for the prevention and control of cervical cancer in key populations and for tobacco control. As far as we know, research on the burden of cervical cancer attributable to smoking is lacking.

OBJECTIVE

We estimated the disease burden and mortality of cervical cancer attributable to smoking and related trends over time at the global, regional, and national levels.

METHODS

Data were obtained from the Global Burden of Disease study website. Age-standardized rates were used to facilitate comparisons of mortality and disability-adjusted life years (DALYs) at different levels. The estimated annual percentage change (EAPC) was used to assess trends in the age-standardized mortality rate (ASMR) and the age-standardized DALY rate (ASDR). A Pearson correlation analysis was used to evaluate correlations between the sociodemographic index and the age-standardized rates.

RESULTS

In 2019, there were 30,136.65 (95% uncertainty interval [UI]: 14,945.09-49,639.87) cervical cancer-related deaths and 893,735.25 (95% UI 469,201.51-1,440,050.85) cervical cancer-related DALYs attributable to smoking. From 1990 to 2019, the global burden of cervical cancer attributable to smoking showed a decreasing trend around the world; the EAPCs for ASMR and ASDR were -2.11 (95% CI -2.16 to -2.06) and -2.22 (95% CI -2.26 to -2.18), respectively. In terms of age characteristics, in 2019, an upward trend was observed for age in the mortality of cervical cancer attributable to smoking. Analysis of the trend in DALYs with age revealed an initially increasing and then decreasing trend. From 1990 to 2019, the burden of disease in different age groups showed a downward trend. Among 204 countries, 180 countries showed downward trends, 10 countries showed upward trends, and the burden was stable in 14 countries. The Pearson correlation analysis revealed a significant negative correlation between sociodemographic index and the age-standardized rates of cervical cancer attributable to smoking (ρ=-0.228, P<.001 for ASMR and ρ=-0.223, P<.001 for ASDR).

CONCLUSIONS

An increase over time in the absolute number of cervical cancer deaths and DALYs attributable to smoking and a decrease over time in the ASMR and ASDR for cervical cancer attributable to smoking were observed in the overall population, and differences in these variables were also observed between countries and regions. More attention should be paid to cervical cancer prevention and screening in women who smoke, especially in low- and middle-income countries.